Skip to main content
LRMR
NASDAQ Life Sciences

拉里玛治疗公司为Nomlabofusp设定2026年6月BLA目标，预计Q2主要数据

feedReported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$5.769
Mkt Cap
$487.009M
52W Low
$1.61
52W High
$6.42
Market data snapshot near publication time

summarizeSummary

来自拉里玛治疗公司的消息对其主要药物Nomlabofusp提供了重要更新，包括计划于2026年6月提交BLA申请以获得加速批准，以及预计2026年Q2开放标签主要数据。这是在2月下旬宣布FDA突破性治疗指定之后。该公司还确认了FDA对关键监管方面的意见一致，例如皮肤FXN作为潜在的替代终点。另外，更新的公司介绍详细说明了截至2027年Q2的预备现金流，这在最近的1亿美元公开募股之后是一个重要的背景。这些具体的时间表和监管明确性是股价的重要催化剂，提供了药物开发和潜在市场进入的明确路线图。

在该公告发布时，LRMR的交易价格为$5.77，交易所为NASDAQ，所属行业为Life Sciences，市值约为$4.9亿。 52周交易区间为$1.61至$6.42。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed LRMR - Latest Insights

LRMR
Apr 20, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Shareholders to Vote on 100 Million Share Increase, Doubling Authorized Common Stock
Sentiment: Negative
View Wiseek Article
LRMR
Apr 10, 2026, 4:09 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Larimar Therapeutics Seeks Shareholder Approval to Double Authorized Common Stock
Sentiment: Negative
View Wiseek Article
LRMR
Mar 19, 2026, 3:41 PM EDT
Filing Type: 10-K
Importance Score:
8
Larimar Therapeutics Secures Breakthrough Therapy Designation, FDA Alignment on Surrogate Endpoint, and $107.6M Funding for Nomlabofusp
Sentiment: Positive
View Wiseek Article
LRMR
Mar 19, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Larimar Therapeutics Secures Breakthrough Therapy Designation, Confirms June 2026 BLA Submission, and Extends Cash Runway
Sentiment: Positive
View Wiseek Article
LRMR
Mar 19, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Breakthrough Therapy Designation, Extended Cash Runway Highlight Larimar's Q4 Report
Sentiment: Positive
View Wiseek Article
LRMR
Mar 09, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Larimar Therapeutics Sets June 2026 BLA Target for Nomlabofusp, Q2 Topline Data Expected
Sentiment: Positive
View Wiseek Article
LRMR
Mar 09, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Larimar Therapeutics Updates on Nomlabofusp BLA Path and Extends Cash Runway into Q2 2027
Sentiment: Positive
View Wiseek Article
LRMR
Mar 02, 2026, 7:46 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Deerfield Management Increases Stake in Larimar Therapeutics with $25 Million Offering Participation
Sentiment: Positive
View Wiseek Article
LRMR
Mar 02, 2026, 7:46 PM EST
Filing Type: 4
Importance Score:
9
Deerfield Management Makes $25M Open Market Purchase in Larimar Therapeutics
Sentiment: Positive
View Wiseek Article
LRMR
Feb 26, 2026, 4:20 PM EST
Filing Type: 424B5
Importance Score:
9
Larimar Therapeutics Prices $100M Public Offering at 16% Discount to Fund Breakthrough Therapy Development
Sentiment: Neutral
View Wiseek Article